We are pleased to present below all posts archived in 'May, 2017'. If you still can't find what you are looking for, try using the search box.
Oxford, UK – 25 May 2017. Oxford Gene Technology (OGT), The Molecular Genetics Company, has made several advances in hybridisation-based target enrichment protocols that now enable researchers to prepare samples for sequencing in just one day. Researchers can now access the high-quality results of hybridisation-based targeted sequencing with a speed comparable to that of amplicon-based approaches.
Read the rest of entry »
The IMMY CrAg® LFA (Cryptococcal Antigen Lateral Flow Assay) is the first and only immunochromatographic dipstick assay for the qualitative and semi-quantitative detection of the cryptococcal capsular antigen in serum, plasma and cerebrospinal fluid (CSF). Available exclusively in the UK from Alpha Laboratories Ltd., it has revolutionised cryptococcal antigen testing, delivering excellent sensitivity across all serotypes of Cryptococcus. CrAg LFA can detect all four CrAg serotypes with improved sensitivity for C. gattii infections (Serotype C).
Belgium, 16 May 2017 – Multiplicom, an Agilent Technologies Company, announced today the extended CE-IVD certification of its BRCA MASTR Plus Dx. This next-generation molecular diagnostic solution uniquely detects both germline* (inherited) and somatic (acquired) mutations in BRCA1 and BRCA2 genes. In combination with the MASTR Reporter, both an analysis software and a quality control tool, it is the one solution for all BRCA mutation testing needs.
SpeciSafe® secondary packaging containers provide a safe, convenient and economical solution for UN3373 compliant mailing of biological and clinical specimens. The extensive range includes solutions for screw cap microtubes, vacuum blood collection tubes, cryovials, Universal and Bijou containers, plus swabs/transport tubes.
Cardiff, UK – 2nd May 2017 – EKF Diagnostics, the global in vitro diagnostics company, announces that it is expanding the distribution of its Procalcitonin LiquiColor® Test into Eastern Europe, Middle East and APAC regions. Procalcitonin (PCT) is a marker for bacterial infection and sepsis, a condition that has grown in awareness in recent years. PCT is now widely recognized as an important adjunct marker in sepsis diagnosis which aids in the differentiation between viral and bacterial infections.
BBI Solutions is pleased to announce that it has triumphed at the DxMA’s 2017 Dx Creative Awards, winning the New IVD Product Launch (less than $100m) category for the market release of its Morffi™ signal enhancement technology. The awards ceremony (held in New Orleans, USA, on the 30th of April) was an opportunity to celebrate the latest innovations in the diagnostics field ahead of the DxMA Global Marketing Summit on the 1st of May, where BBI’s Dr Neil Polwart was also presenting the company’s Novarum Dx mobile assay reader.
Who are the BIVDA Members
Member Press Releases
Point of Care Directory
News, Policy and Media
BIVDA Press Releases